Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

Also called NCT07837934

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07837934
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Singapore (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07837934. Randomized; quadruple masking; primary purpose prevention. Start 2025-07-24 (actual); primary completion 2027-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes
Acronym
Col-DM
Condition
Type 2 Diabetes Mellitus (T2DM)
Condition
Atherosclerosis
Condition
Cardiovascular Diseases
Intervention (Drug)
Colchicine 0.5 MG Oral Tablet Once Daily
Intervention (Drug)
Placebo
Lead sponsor
Tan Tock Seng Hospital (class: other)
Collaborator
Nanyang Technological University (class: other)

Record details

Record id
cardio:ct-nct07837934
Content hash
ad88098a9048164fc43211aa59179c1098454d01f6145792e322d12870cf746f